Treatment for pancreatic cancer

Current therapy and continued progress

Albert Lockhart, Mace L. Rothenberg, Jordan D. Berlin

Research output: Contribution to journalReview article

128 Citations (Scopus)

Abstract

In the last decade, continued efforts in pancreas cancer research have led to the development of new, more effective therapies. Additionally, progress in understanding the molecular processes underlying the development and progression of this disease provides hope for the development of more effective treatment strategies. Recent clinical trials have provided reason for hope that novel chemotherapy combinations and molecularly targeted agents will lead to improved clinical outcomes for patients with this disease. This article will summarize the data that has led to the current standards of therapy for patients with resectable and advanced pancreatic cancer and review new treatment strategies for this disease.

Original languageEnglish (US)
Pages (from-to)1642-1654
Number of pages13
JournalGastroenterology
Volume128
Issue number6
DOIs
StatePublished - Jan 1 2005
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Therapeutics
Combination Drug Therapy
Disease Progression
Clinical Trials
Research

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Treatment for pancreatic cancer : Current therapy and continued progress. / Lockhart, Albert; Rothenberg, Mace L.; Berlin, Jordan D.

In: Gastroenterology, Vol. 128, No. 6, 01.01.2005, p. 1642-1654.

Research output: Contribution to journalReview article

Lockhart, Albert ; Rothenberg, Mace L. ; Berlin, Jordan D. / Treatment for pancreatic cancer : Current therapy and continued progress. In: Gastroenterology. 2005 ; Vol. 128, No. 6. pp. 1642-1654.
@article{54b696ab60f64a53bd09b9099be73270,
title = "Treatment for pancreatic cancer: Current therapy and continued progress",
abstract = "In the last decade, continued efforts in pancreas cancer research have led to the development of new, more effective therapies. Additionally, progress in understanding the molecular processes underlying the development and progression of this disease provides hope for the development of more effective treatment strategies. Recent clinical trials have provided reason for hope that novel chemotherapy combinations and molecularly targeted agents will lead to improved clinical outcomes for patients with this disease. This article will summarize the data that has led to the current standards of therapy for patients with resectable and advanced pancreatic cancer and review new treatment strategies for this disease.",
author = "Albert Lockhart and Rothenberg, {Mace L.} and Berlin, {Jordan D.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1053/j.gastro.2005.03.039",
language = "English (US)",
volume = "128",
pages = "1642--1654",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Treatment for pancreatic cancer

T2 - Current therapy and continued progress

AU - Lockhart, Albert

AU - Rothenberg, Mace L.

AU - Berlin, Jordan D.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - In the last decade, continued efforts in pancreas cancer research have led to the development of new, more effective therapies. Additionally, progress in understanding the molecular processes underlying the development and progression of this disease provides hope for the development of more effective treatment strategies. Recent clinical trials have provided reason for hope that novel chemotherapy combinations and molecularly targeted agents will lead to improved clinical outcomes for patients with this disease. This article will summarize the data that has led to the current standards of therapy for patients with resectable and advanced pancreatic cancer and review new treatment strategies for this disease.

AB - In the last decade, continued efforts in pancreas cancer research have led to the development of new, more effective therapies. Additionally, progress in understanding the molecular processes underlying the development and progression of this disease provides hope for the development of more effective treatment strategies. Recent clinical trials have provided reason for hope that novel chemotherapy combinations and molecularly targeted agents will lead to improved clinical outcomes for patients with this disease. This article will summarize the data that has led to the current standards of therapy for patients with resectable and advanced pancreatic cancer and review new treatment strategies for this disease.

UR - http://www.scopus.com/inward/record.url?scp=18844375044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18844375044&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2005.03.039

DO - 10.1053/j.gastro.2005.03.039

M3 - Review article

VL - 128

SP - 1642

EP - 1654

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 6

ER -